Amarillo Biosciences Inc AMAR:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
0.40quote price arrow down-0.12 (-23.0769%)
Volume
2,507
52 week range
0.05 - 0.59

...

Loading . . .

KEY STATS

  • Open0.40
  • Day High0.40
  • Day Low0.40
  • Prev Close0.52
  • 52 Week High0.59
  • 52 Week High Date02/10/21
  • 52 Week Low0.05
  • 52 Week Low Date10/08/20
  • Market Cap16.41M
  • Shares Out41.02M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.29
  • 1 Year % Change34.23

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-11.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.367M
  • ROE (MRQ)-2,639.61%
  • Revenue (MRQ)20,000.00
  • Gross Margin (MRQ)26.42%
  • Net Margin (MRQ)-7,569.00%
  • Debt To Equity (MRQ)-81.49%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Amarillo Biosciences Inc News

There is no recent news for this security.

Latest AMAR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development. The Company develops biologics for the treatment of human and animal diseases. The Company's focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia and other indications using natural human interferon alpha that is administered in a low dose oral form. The Company owns or licenses approximately two issued...
Stephen Chen Ph.D.
Chairman
Address
4134 Business Park Dr
Amarillo, TX
79110-4225
United States